Sales 77,753 - Santen
2017-1-18 · ophthalmic products after cataract and other ocular surgeries. Anti-Infective Ophthalmics Market Trends In December 2008, Santen introduced Tapros, which meets the treatment needs of patients with glaucoma and ocular hypertension. Reflecting steady market penetration, Tapros sales grew 9.1% year on year in fiscal 2011, to ¥7,179 million.
Get Price